Tumor microenvironment evaluation to predict anti-PD-1 response of advanced gastric cancer: Results from a multicenter prospective clinical trial.

被引：0
|
作者：
Liao, Wangjun
Shi, Min
Zeng, Dongqiang
Luo, Huiyan
Xiao, Jian
Ye, Feng
Xiong, Hailin
Yuan, Xia
Huang, Yisheng
Li, Yongqiang
Huang, Na
Wu, Jianhua
Li, Shaowei
Zheng, Siting
Wu, Jiani
Sun, Li
Rong, Xiaoxiang
Wang, Chunlin
Guo, Jian
Deng, Qiong
机构：
[1] Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Peoples R China
[2] Sun Yat sen Univ, Canc Ctr, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangzhou, Peoples R China
[4] Xiamen Univ, Dept Med Oncol, Affiliated Hosp 1, Xiamen, Peoples R China
[5] Huizhou First Hosp, Dept Med Oncol, Huizhou, Peoples R China
[6] Maoming Peoples Hosp, Dept Oncol, Maoming, Peoples R China
[7] Guangxi Med Univ, Dept Med Oncol, Canc Hosp, Nanning, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
415
引用
收藏
页码：415 / 415
页数：1
相关论文
共 50 条
  • [41] The Negative Impact of Obesity on the Tumor Microenvironment in Colon Cancer: Results From a Prospective Trial
    Flaherty, Devin C.
    Lavotshkin, Simon
    Jalas, John R.
    Torisu-Itakura, Hitoe
    Sim, Myung S.
    Lee, Delphine J.
    Bilchik, Anton J.
    GASTROENTEROLOGY, 2016, 150 (04) : S1195 - S1195
  • [42] Tumor microenvironment RNA test to predict immunotherapy outcomes in advanced gastric cancer: The TIMES001 trial
    Shi, Min
    Zeng, Dongqiang
    Luo, Huiyan
    Xiao, Jian
    Li, Yongqiang
    Yuan, Xia
    Huang, Na
    Wu, Jiani
    Zheng, Siting
    Wu, Jianhua
    Li, Shaowei
    Rong, Xiaoxiang
    Wang, Chunlin
    Jiang, Luyang
    Mao, Qianqian
    Qiu, Wenjun
    Guo, Jian
    Deng, Qiong
    Sun, Huiying
    Lu, Xiansheng
    Yu, Yunfang
    Lai, Yonghong
    Fang, Yiran
    Zhou, Rui
    Wang, Ling
    Huang, Xiatong
    Kong, Yuyun
    Li, Jun
    Liang, Li
    Bin, Jianping
    Liao, Yulin
    Liao, Wangjun
    MED, 2024, 5 (11):
  • [43] Using deep learning to predict anti-PD-1 response in melanoma and lung cancer patients from histopathology images
    Hu, Jing
    Cui, Chuanliang
    Yang, Wenxian
    Huang, Lihong
    Yu, Rongshan
    Liu, Siyang
    Kong, Yan
    TRANSLATIONAL ONCOLOGY, 2021, 14 (01):
  • [44] Combination of SABR With Anti-PD-1 in Oligoprogressive Non-Small Cell Lung Cancer and Melanoma: Results of a Prospective Multicenter Observational Study
    Chicas-Sett, Rodolfo
    Zafra, Juan
    Rodriguez-Abreu, Delvys
    Castilla-Martinez, Juan
    Benitez, Gretel
    Salas, Barbara
    Hernandez, Samuel
    Lloret, Marta
    Onieva, Juan Luis
    Barragan, Isabel
    Lara, Pedro C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (04): : 655 - 665
  • [45] Prior antibiotic administration disrupts anti-PD-1 responses in advanced gastric cancer by altering the gut microbiome and systemic immune response
    Kim, Chang Gon
    Koh, June-Young
    Shin, Su-Jin
    Shin, Ji-Hee
    Hong, Moonki
    Chung, Hyun Cheol
    Rha, Sun Young
    Kim, Hyo Song
    Lee, Choong-Kun
    Lee, Ji Hyun
    Han, Yejeong
    Kim, Hyoyong
    Che, Xiumei
    Yun, Un-Jung
    Kim, Hyunki
    Kim, Jee Hung
    Lee, Seo Young
    Park, Su Kyoung
    Park, Sejung
    Kim, Hyunwook
    Ahn, Jin Young
    Jeung, Hei-Cheul
    Lee, Jeong Seok
    Nam, Young-Do
    Jung, Minkyu
    CELL REPORTS MEDICINE, 2023, 4 (11)
  • [46] The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer
    Peng, Zhi
    Cheng, Siyuan
    Kou, Yan
    Wang, Ziqi
    Jin, Rong
    Hu, Han
    Zhang, Xiaotian
    Gong, Ji-fang
    Li, Jian
    Lu, Ming
    Wang, Xicheng
    Zhou, Jun
    Lu, ZhiHao
    Zhang, Quan
    Tzeng, David T. W.
    Bi, Dongtao
    Tan, Yan
    Shen, Lin
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (10) : 1251 - 1261
  • [47] Gls-010, a novel anti-PD-1 mAb in Chinese patients with recurrent or metastatic cervical cancer: Results from a multicenter, open-label and single-arm phase II trial.
    Wu, Xiaohua
    Xia, Lingfang
    Zhou, Qi
    Zhu, Jianqing
    Wang, Ke
    Chen, Jie
    Huang, Yi
    Kurb, Gulina
    Chang, Baoping
    Zhao, Weidong
    Wang, Xia
    Yang, Yingjie
    Lin, Zhongqiu
    Luo, Xiaoyong
    Lou, Ge
    Wang, Chunyan
    Wang, Jing
    Meng, Haijin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [48] Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients
    Basak, Edwin A.
    van der Meer, Jan W. M.
    Hurkmans, Daan P.
    Schreurs, Marco W. J.
    Oomen-de Hoop, Esther
    van der Veldt, Astrid A. M.
    Bins, Sander
    Joosse, Arjen
    Koolen, Stijn L. W.
    Debets, Reno
    Peeters, Robin P.
    Aerts, Joachim G. J., V
    Mathijssen, Ron H. J.
    Medici, Marco
    THYROID, 2020, 30 (07) : 966 - 973
  • [49] Necroptosis is Related to Anti-PD-1 Treatment Response and Influences the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma
    Wang, Qiwei
    Wang, Fang
    Zhao, Yinan
    Tan, Guolin
    FRONTIERS IN GENETICS, 2022, 13
  • [50] The safety and efficacy of anti-PD-1/anti-PD-L1 antibody therapy in the treatment of previously treated, advanced gastric or gastro-oesophageal junction cancer: A meta-analysis of prospective clinical trials
    Ni, Xiaofei
    Xing, Yanpeng
    Sun, Xuan
    Suo, Jian
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2020, 44 (02) : 211 - 222
12345